ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Clinica Chimica Acta
Volume 131, Issue 3, 15 July 1983, Pages 273-281
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Purchase PDF (749 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/0009-8981(83)90096-7    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 1983 Published by Elsevier B.V.

Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Barry WolfCorresponding Author Contact Information, a, Robert E. Griera, Richard J. Allenb, Stephen I. Goodmanc and Craig L. Kiend

aDepartment of Human Genetics and Department of Pediatrics, Children's Medical Center, Medical College of Virginia, Richmond, VA 23298 USA

bDepartments of Pediatrics and Neurology, Section of Pediatric Neurology, University of Michigan Medical Center, Ann Arbor, MI 48109 USA

cDepartment of Pediatrics, University of Colorado School of Medicine, Denver, CO 80262 USA

dDepartments of Pediatrics and Biochemistry, Medical College of Wisconsin and the Milwaukee Children's Hospital, Milwaukee, WI5 3233 USA


Received 20 January 1983; 
revised 20 March 1983. 
Available online 15 January 2003.

Abstract

Late-onset multiple carboxylase deficiency is characterized clinically by skin rash, alopecia, seizures and ataxia and occasionally by candidiasis and developmental delay. Biochemically, these individuals exhibit findings consistent with a combined deficiency of the biotin-dependent carboxylases. We have found that the activity of the enzyme biotinidase is also deficient in the sera of five affected children (0 to 3% of mean control activity, 5.80 ± 0.89 nmol · min · ml serum), and believe that it represents the primary biochemical defect in this disease. Biotinidase catalyzes the removal of biotin from the epsilon (Porson)-amino group of lysine, through which biotin is covalently bound to the four known human carboxylases, thereby regenerating biotin for reutilization. The deficient activity in our patients was not due to an inhibitor, particularly biotin. It is also not a consequence of feedback control in affected individuals under treatment with pharmacologie doses of biotin. The biotinidase activities of the parents of those children who were available for study were intermediate between deficient and normal values (46% to 65% of mean normal activity). Children lacking biotinidase activity are unable to recycle biotin, and are thus entirely dependent upon exogenous biotin to prevent deficiency. Our findings indicate that the primary biochemical defect in late-onset multiple carboxylase deficiency is in biotinidase activity which is inherited as an autosomal recessive trait.


Corresponding Author Contact InformationCorrespondent: Barry Wolf, Department of Human Genetics, Medical College of Virginia, P.O. Box 33, MCV Station, Richmond, VA 23298, USA.

Clinica Chimica Acta
Volume 131, Issue 3, 15 July 1983, Pages 273-281
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.